In addition to some targeted drugs, previous studies have shown that nanoparticles remove both VEGF and PIGF from M2-TAMs and BCCs, remodeling the tumor-immunosuppressed TME to an antitumor state. The gene discussed is VEGFA; the disease is neoplasm.